ORIEL THERAPEUTICS
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care. Combining an experienced product development team and a growing portfolio of innovative drug delivery technologies, Oriel is focused on delivering compelling patient options for the treatment of asthma and COPD.
ORIEL THERAPEUTICS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2001-01-01
Address:
Tarboro, North Carolina, United States
Country:
United States
Website Url:
http://www.orieltherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
919-313-1290
Email Addresses:
[email protected]
Total Funding:
26.5 M USD
Technology used in webpage:
SPF GoDaddy DNS SMTP.com
Current Employees Featured
Founder
Investors List
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Oriel Therapeutics
Official Site Inspections
http://www.orieltherapeutics.com
Unable to get host informations!!!
More informations about "Oriel Therapeutics"
Oriel Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Oriel Therapeutics, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Oriel Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Oriel Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Oriel Therapeutics - Crunchbase Company Profile
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care.See details»
Organization | Oriel Therapeutics
Oriel Therapeutics Report issue For profit Phase 1 Founded: Tarboro NC United States (2001) Status: Acquired by Sandoz (2010) → now Novartis (1996) Organization Overview First …See details»
Oriel Therapeutics - 2025 Company Profile - Tracxn
Mar 28, 2025 Oriel Therapeutics - Develops respiratory care drugs. Raised a total funding of $26.5M over 1 round from 4 investors.See details»
Orel Therapeutics
We would like to show you a description here but the site won’t allow us.See details»
OrielTherapeutics.com - AboutUs
About OrielTherapeutics.com Welcome!Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care. Combining an …See details»
Oriel Therapeutics, Inc.:Company Profile & Technical Research ...
Discovery Company profile page for Oriel Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Oriel Therapeutics - Products, Competitors, Financials, Employees ...
Oriel Therapeutics is a respiratory drug delivery company developing dry powder delivery systems for the treatment of asthma and COPD. On April 19, 2010, Oriel Therapeutics was acquired by …See details»
Novartis Announces Changes in U.S. Operations, Acquires Oriel …
Apr 19, 2010 Novartis to Overhaul U.S. Operations Swiss pharma major Novartis has announced a number of organisational changes in its U.S. operations, according to an email …See details»
Oriel Therapeutics - Funding, Financials, Valuation & Investors
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care.See details»
Sandoz-Acquire-Oriel-Therapeutics
Apr 26, 2010 Sandoz, the generic drug arm of Novartis, will purchase privately held Oriel Therapeutics for an undisclosed amount. North Carolina-based Oriel develops generics and …See details»
Sandoz signs agreement with Oriel Therapeutics
Apr 19, 2010 teaser Sandoz has signed a definitive agreement to acquire Oriel Therapeutics, a privately held US pharmaceuticals company. This means gaining exclusive rights to a portfolio …See details»
Oriel Therapeutics - LinkedIn
Oriel Therapeutics | 253 followers on LinkedIn.See details»
NOVARTIS : Sandoz to acquire Oriel Therapeutics, gaining rights to ...
Apr 19, 2010 Novartis International AG / Sandoz to acquire Oriel Therapeutics, gaining rights to portfolio of respiratory products targeting asthma and COPD processed and transmitted by …See details»
Oriel Therapeutics CEO, Founder, Key Executive Team, Board of …
Explore {Oriel Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Oriel Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Oriel Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 1 literature, Drug:OT-121.See details»
Viralgen Joins Orphan Therapeutics Accelerator Clinical …
3 days ago Based in San Sebastián, Spain, Viralgen is a Contract Development and Manufacturing Organization dedicated to AAV gene therapy production across clinical and …See details»
Sandoz/Novartis buy Oriel Therapeutics, gaining rights to portfolio …
Apr 19, 2010 Swiss drug major Novartis' generics subsidiary Sandoz has signed a definitive agreement to acquire Oriel Therapeutics, a privately-held US company, gaining exclusive …See details»
Oriel Research Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Oriel Research Therapeutics. Use the PitchBook Platform to explore the full profile.See details»